Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2018-99-115922

Published: 2018

Journal Articles

Vaccine therapy in hematologic malignancies

David Avigan, Jacalyn Rosenblatt

Blood (2018) 131 (24): 2640–2650.

https://doi.org/10.1182/blood-2017-11-785873

Published: 2018

Journal Articles

Identification and Validation of HLA-A24 XBP1 us , XBP1 sp , CD138, and CS1 Peptides to Generate Antigens Specific-Cytotoxic T Lymphocytes: Preclinical Basis for Vaccine Therapy in HLA-A24 Patients with Multiple Myeloma and Other Cancers

Jooeun Bae, PhD, Brandon Nguyen, Matthew Ho, Yan Song, PhD, Noopur Raje, MD, Paul G. Richardson, MD, Teru Hideshima, MD PhD, Dharminder Chauhan, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 5689.

https://doi.org/10.1182/blood.V128.22.5689.5689

Published: 2016

Journal Articles

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Bijal D. Shah, MD, Jianguo Tao, MD PhD, Paul A. Chervenick, MD, Marcie L Riches, MD MS, Javier Pinilla-Ibarz, MD PhD, Lynn C. Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, MD, Sophie Dessureault, MD

Blood (2014) 124 (21): 3083.

https://doi.org/10.1182/blood.V124.21.3083.3083

Published: 2014

Journal Articles

Matched Case Control Analysis Comparing Long Term Survival of Multiple Myeloma Patients Who Received Stem Cell Transplant with and without Idiotype-Pulsed Dendritic Cell Vaccine

Yi Lin, MD PhD, Morie A Gertz, MD, Robert B. Sims, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Betsy LaPlant, Angela Dispenzieri, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Douglas Padley, Dennis A. Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, MD, Martha Q Lacy, MD

Blood (2011) 118 (21): 636.

https://doi.org/10.1182/blood.V118.21.636.636

Published: 2011

Journal Articles

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Bijal D. Shah, MD, Jianguo Tao, MD, PhD, Lubomir Sokol, MD, PhD, Paul A. Chervenick, MD, Marcie Tomblyn, MD, MS, Javier Pinilla-Ibarz, MD, PhD, Lynn Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, Sophie Dessureault, MD

Blood (2011) 118 (21): 3720.

https://doi.org/10.1182/blood.V118.21.3720.3720

Published: 2011

Journal Articles

A Cytotoxic Human Monoclonal Antibody Recognizing Cell Surface WT1 Peptide/HLA-A2 Complexes

David A. Scheinberg, MD, PhD, Tao Dao, MD, PhD, Su Yan, PhD, Liang Zhou, PhD, Tatyana Korontsvit, Victoriya Zakhaleva, Michael Curcio, Cheng Liu, PhD

Blood (2011) 118 (21): 1677.

https://doi.org/10.1182/blood.V118.21.1677.1677

Published: 2011

Journal Articles

A Phase I Pilot Study of Bystander Vaccine and Lenalidomide Immune Augmentation In Patients with Myelodysplastic Syndrome (MDS)

Eric Padron, MD, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Sophie Dessureault, Scott Antonia, Jamil Ahmed, Shiddhi Patel, John Powers, Fanqi Bai, Eduardo M. Sotomayor, MD, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD

Blood (2010) 116 (21): 2925.

https://doi.org/10.1182/blood.V116.21.2925.2925

Published: 2010

Journal Articles

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

Yi Lin, MDPhD, Morie Gertz, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Douglas Padley, Dennis Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, Martha Lacy, MD

Blood (2010) 116 (21): 1958.

https://doi.org/10.1182/blood.V116.21.1958.1958

Published: 2010

Journal Articles

Novel Anti-CD19/Idiotype Bispecific Diabody Vaccine for B-Cell Lymphoma.

Patrick P. Ng, Ming Jia, Alejandro Virrueta, Kedar Patel, James R. Swartz, Shoshana Levy, Ronald Levy

Blood (2009) 114 (22): 2712.

https://doi.org/10.1182/blood.V114.22.2712.2712

Published: 2009

Journal Articles

Post Autologous Transplantation Consolidation of Multiple Myeloma with Idiotype-Pulsed Antigen Presenting (Dendritic) Cells (APC8020) Is Associated with Prolonged Survival.

Martha Q. Lacy, MD, Sumithra Mandrekar, Brian Kabat, Angela Dispenzieri, Suzanne Hayman, Shaji Kumar, Francis Buadi, David Dingli, Mark Litzow, Peter Wettstein, S. Vincent Rajkumar, Dennis Gastineau, Morie A. Gertz, MD

Blood (2008) 112 (11): 1739.

https://doi.org/10.1182/blood.V112.11.1739.1739

Published: 2008

Journal Articles

Polyclonal PRAME-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Concetta Quintarelli, PhD, Gianpietro Dotti, MD, Biagio De Angelis, PhD, Valentina Hoyos, MD, Fabrizio Pane, MD, Martha P. Mims, MD, PhD, Helen E. Heslop, MD, Cliona M Rooney, PhD, Malcolm K Brenner, MD, PhD, Barbara Savoldo, MD

Blood (2008) 112 (11): 3899.

https://doi.org/10.1182/blood.V112.11.3899.3899

Published: 2008

Journal Articles

Lenalidomide Enhances Leukaemia Specific T Cell Responses to Dendritic Cell Based Immunotherapy for Myeloid Leukaemias.

Caroline J Duncan, MBBS, MRCP(Ed), Peter R. E. Johnson, MD, Huw Roddie, MBChB, PhD

Blood (2008) 112 (11): 1954.

https://doi.org/10.1182/blood.V112.11.1954.1954

Published: 2008

Journal Articles

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

Sophie Dessureault, MD, PhD, David Noyes, BSc, Jianguo Tao, MD, Lynn Moscinski, MD, Michael Schell, PhD, Scott J. Antonia, MD, PhD, Eduardo M. Sotomayor, MD

Blood (2007) 110 (11): 4483.

https://doi.org/10.1182/blood.V110.11.4483.4483

Published: 2007

Journal Articles

BiovaxID Vaccine Therapy of Follicular Lymphoma in First Remission: Phase III Blinded Safety Update.

Angelos M. Stergiou, MD, Sattva S. Neelapu, MD, Roman Casciano, MS, Margo A. Jaffee, Larry W. Kwak, MD

Blood (2007) 110 (11): 4500.

https://doi.org/10.1182/blood.V110.11.4500.4500

Published: 2007

Journal Articles

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Edna Ku, MD, PhD, JianXiang Zou, MD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 2659.

https://doi.org/10.1182/blood.V108.11.2659.2659

Published: 2006

Journal Articles

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Nikoletta Lendvai, MD, PhD, Sacha Gnjatic, PhD, Erika Ritter, Yao-Tseng Chen, MD, PhD, Christina Coughlin, MD, PhD, Robert H. Vonderheide, MD, DPhil, Ruben Niesvizky, MD, Nina Bhardwaj, MD, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Hearn J. Cho, MD, PhD

Blood (2006) 108 (11): 3492.

https://doi.org/10.1182/blood.V108.11.3492.3492

Published: 2006

Journal Articles

Vaccination with Dendritic Cell Myeloma Fusions Alone or in Conjunction with Stem Cell Transplantation for Patients with Multiple Myeloma.

David Avigan, MD, Jacalyn Rosenblatt, MD, Baldev Vasir, PhD, Zekui Wu, MD, Adam Bissonnette, Claire MacNamara, Lynne Uhl, MD, Corrine Lenahan, MD, Kenneth Miller, MD, Robin Joyce, MD, James D. Levine, MD, Joanne Proper, RN, Patricia Forino, RN, Dilani Dombagoda, Paul Richardson, MD, Nikhil C. Munshi, MD, Donald Kufe, MD

Blood (2006) 108 (11): 3080.

https://doi.org/10.1182/blood.V108.11.3080.3080

Published: 2006

Journal Articles

Hematopoietic Stem Cells and Primitive Progenitors Express Leukemia-Associated Antigens That May Be Targets for Graft-Versus-Leukemia Effect or for Vaccine-Based Immunotherapy in Chronic Myeloid Leukemia.

Agnes S.M. Yong, MD, PhD, Keyvan Keyvanfar, BS, Rhoda Eniafe, BS, Bipin N. Savani, MD, Elaine M. Sloand, MD, John M. Goldman, MD, A. John Barrett, MD

Blood (2006) 108 (11): 2125.

https://doi.org/10.1182/blood.V108.11.2125.2125

Published: 2006

Journal Articles

BiovaxID™ Vaccine Therapy of Follicular Lymphoma in First Remission: Long-Term Follow-Up of a Phase II Trial and Status of a Controlled, Randomized Phase III Trial.

Carlos Santos, MS, Lee Stern, MS, Laura Katz, MS, Thelma Watson, Gause Barry, MD

Blood (2005) 106 (11): 2441.

https://doi.org/10.1182/blood.V106.11.2441.2441

Published: 2005

NARROW

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Vaccine therapy in hematologic malignancies

Identification and Validation of HLA-A24 XBP1 us , XBP1 sp , CD138, and CS1 Peptides to Generate Antigens Specific-Cytotoxic T Lymphocytes: Preclinical Basis for Vaccine Therapy in HLA-A24 Patients with Multiple Myeloma and Other Cancers

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Matched Case Control Analysis Comparing Long Term Survival of Multiple Myeloma Patients Who Received Stem Cell Transplant with and without Idiotype-Pulsed Dendritic Cell Vaccine

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

A Cytotoxic Human Monoclonal Antibody Recognizing Cell Surface WT1 Peptide/HLA-A2 Complexes

A Phase I Pilot Study of Bystander Vaccine and Lenalidomide Immune Augmentation In Patients with Myelodysplastic Syndrome (MDS)

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

Novel Anti-CD19/Idiotype Bispecific Diabody Vaccine for B-Cell Lymphoma.

Post Autologous Transplantation Consolidation of Multiple Myeloma with Idiotype-Pulsed Antigen Presenting (Dendritic) Cells (APC8020) Is Associated with Prolonged Survival.

Polyclonal PRAME-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Lenalidomide Enhances Leukaemia Specific T Cell Responses to Dendritic Cell Based Immunotherapy for Myeloid Leukaemias.

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

BiovaxID Vaccine Therapy of Follicular Lymphoma in First Remission: Phase III Blinded Safety Update.

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Vaccination with Dendritic Cell Myeloma Fusions Alone or in Conjunction with Stem Cell Transplantation for Patients with Multiple Myeloma.

Hematopoietic Stem Cells and Primitive Progenitors Express Leukemia-Associated Antigens That May Be Targets for Graft-Versus-Leukemia Effect or for Vaccine-Based Immunotherapy in Chronic Myeloid Leukemia.

BiovaxID™ Vaccine Therapy of Follicular Lymphoma in First Remission: Long-Term Follow-Up of a Phase II Trial and Status of a Controlled, Randomized Phase III Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only